الهيئة السعودية للمراجعين الداخليين Saia company information, Employees & Contact Information

Procollagen IIA mediates positive feedback control of the mouse cardiogenic transcriptional network PNAS

IIA SA reflects on AFIIA 2025’s success, gears up for 2026 CT hosting ITWeb

Tanshinone IIA Loaded Inhaled Polymer Nanoparticles Alleviate Established Pulmonary Fibrosis ACS Publications

Multimodal regulation of the osteoclastogenesis process by secreted group IIA phospholipase A2 Frontiers

Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment–Elevation Myocardial Infarction (STEMI) American Heart Association Journals

A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss Nature

IIA SA celebrates UP for global recognition for academic excellence in internal auditing ITWeb

Myosin IIA-related Actomyosin Contractility Mediates Oxidative Stress-induced Neuronal Apoptosis Frontiers

Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury American Heart Association Journals

Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation PNAS

IIA SA and CIGFARO: New chapter of collaboration for professional development, capacity building ITWeb

Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction Frontiers

Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment–Elevation Myocardial Infarction (STEMI) American Heart Association Journals

Tanshinone IIA delays liver aging by modulating oxidative stress Frontiers

Tanshinone IIA: A Review of its Anticancer Effects Frontiers

TMP269, a small molecule inhibitor of class IIa HDAC, suppresses RABV replication in vitro Frontiers

Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya Frontiers

MiR-122 overexpression alleviates oxygen–glucose deprivation-induced neuronal injury by targeting sPLA2-IIA Frontiers

Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway Frontiers

Heterologous Expression of the Class IIa Bacteriocins, Plantaricin 423 and Mundticin ST4SA, in Escherichia coli Using Green Fluorescent Protein as a Fusion Partner Frontiers

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice Frontiers

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer Nature

Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity Nature

Involvement of aph(3′)-IIa in the formation of mosaic aminoglycoside resistance genes in natural environments Frontiers

Missile Interceptors by Cost Missile Defense Advocacy Alliance

The role of class IIa histone deacetylases in regulating endothelial function Frontiers

Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis Nature

Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa Trial Frontiers

Class II (IIa)-Selective Histone Deacetylase Inhibitors. 1. Synthesis and Biological Evaluation of Novel (Aryloxopropenyl)pyrrolyl Hydroxyamides ACS Publications

Functional Genomic Validation of the Roles of Soluble Starch Synthase IIa in Japonica Rice Endosperm Frontiers

STROKE34 Study Protocol: A Randomized Controlled Phase IIa Trial of Intra-Arterial CD34+ Cells in Acute Ischemic Stroke Frontiers

Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease ACS Publications

Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof Nature

Purification and Characterization of Plantaricin LPL-1, a Novel Class IIa Bacteriocin Produced by Lactobacillus plantarum LPL-1 Isolated From Fermented Fish Frontiers

Crystal structure of the S100A4–nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism PNAS

Synapsin IIa Controls the Reserve Pool of Glutamatergic Synaptic Vesicles Journal of Neuroscience

Exploring Hydrophobic Subdomain IIA of the Protein Bovine Serum Albumin in the Native, Intermediate, Unfolded, and Refolded States by a Small Fluorescence Molecular Reporter ACS Publications

IIA South Africa wins bid to host AFIIA Week 2026 ITWeb